William McIsaac is a Senior Associate, Sagard Healthcare at Sagard and joined the firm in 2020. As a member of Sagard Healthcare, William invests in approved and commercialized biopharmaceuticals, diagnostics, and medical devices that are protected by strong intellectual property. He is responsible for all aspects of the investment process, including origination, due diligence, execution, and portfolio management. William is based in Toronto, Canada.
Prior to Sagard, William was an Analyst at DRI Capital where he was responsible for making royalty and structured credit investments in the biopharmaceutical industry.
William holds a B.Sc and M.Sc in Neuroscience from Queen’s University and an MBA from Queen’s University, Smith School of Business. He is also a CFA® charterholder.
